{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:15:36Z","timestamp":1761714936700,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","primary-care-diabetes.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care Diabetes"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.pcd.2014.09.003","type":"journal-article","created":{"date-parts":[[2014,10,11]],"date-time":"2014-10-11T02:51:20Z","timestamp":1412995880000},"page":"231-236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Latent autoimmune diabetes amongst adults with type 2 diabetes in a Nigerian tertiary hospital"],"prefix":"10.1016","volume":"9","author":[{"given":"Arinola","family":"Ipadeola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jokotade O.","family":"Adeleye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kehinde S.","family":"Akinlade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcd.2014.09.003_bib0005","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jdiacomp.2005.02.004","article-title":"The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus","volume":"19","author":"Arikan","year":"2005","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.pcd.2014.09.003_bib0010","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1749-6632.2002.tb02953.x","article-title":"Latent autoimmune diabetes in adults","volume":"958","author":"Landin-Olsson","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pcd.2014.09.003_bib0015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1258\/000456307780945679","article-title":"Latent autoimmune diabetes in adults: increased awareness will aid diagnosis","volume":"44","author":"Fielding","year":"2007","journal-title":"Ann. Clin. Biochem."},{"year":"2003","series-title":"Global Strategy on Diet Physical Activity and Health","author":"WHO","key":"10.1016\/j.pcd.2014.09.003_bib0020"},{"key":"10.1016\/j.pcd.2014.09.003_bib0025","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome \u2013 a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.pcd.2014.09.003_bib0030","unstructured":"World Health Organization, WHO STEPS instrument (core and expanded). In: The WHO STEPwise Approach to Noncommunicable Disease Risk Factor Surveillance (STEPS), Geneva."},{"year":"2004","series-title":"The Seventh Report of the Joint National Committee on Prevention Detection, and Evaluation and Treatment of High Blood Pressure","author":"U.S. Department of Health and Human Services","key":"10.1016\/j.pcd.2014.09.003_bib0035"},{"key":"10.1016\/j.pcd.2014.09.003_bib0040","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2337\/diabetes.48.1.150","article-title":"Clinical and genetic characteristics of type 2 diabetes with or without GAD antibodies","volume":"48","author":"Tuomi","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.pcd.2014.09.003_bib0045","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(97)03062-6","article-title":"UKPDS 25 autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes","volume":"350","author":"Turner","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.pcd.2014.09.003_bib0050","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1046\/j.1464-5491.2000.00324.x","article-title":"Distribution of autoantibodies to glutamic acid decarboxylase across the spectrum of diabetes mellitus seen in South Africa","volume":"7","author":"Panz","year":"2000","journal-title":"Diabetes Med."},{"key":"10.1016\/j.pcd.2014.09.003_bib0055","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1740-2557-4-4","article-title":"Islet cell auto antibodies in African patients with Type 1 and Type 2 diabetes in Dar es Salaam Tanzania: a cross-sectional study","volume":"4","author":"Lutalle","year":"2007","journal-title":"J. Autoimmune Dis."},{"key":"10.1016\/j.pcd.2014.09.003_bib0060","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1047-2797(00)00180-0","article-title":"In search of susceptibility genes for Type 2 diabetes in West Africa: the design and results of the first phase of the AADM study","volume":"11","author":"Rotimi","year":"2001","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.pcd.2014.09.003_bib0065","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.3923\/pjbs.2008.2320.2325","article-title":"The prevalence of autoimmune diabetes among diabetes mellitus patients in Kumasi, Ghana","volume":"11","author":"Agyei Fempong","year":"2008","journal-title":"Pak. J. Biol. Sci."},{"key":"10.1016\/j.pcd.2014.09.003_bib0070","doi-asserted-by":"crossref","DOI":"10.1186\/1755-7682-5-23","article-title":"Latent autoimmune diabetes mellitus in adults(LADA) and it's characteristics in a subset of Nigerians initially managed for type 2 diabetes","author":"Adeleye","year":"2012","journal-title":"Int. Arch. Med."},{"key":"10.1016\/j.pcd.2014.09.003_bib0075","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0168-8227(02)00002-5","article-title":"Prevalence of latent autoimmune diabetes of adults (LADA) in Southern Spain","volume":"56","author":"Soriguer-Escofet","year":"2002","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.pcd.2014.09.003_bib0080","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1046\/j.1464-5491.2000.00359.x","article-title":"Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle diabetes study","volume":"17","author":"Davis","year":"2000","journal-title":"Diabetes Med."},{"key":"10.1016\/j.pcd.2014.09.003_bib0085","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1006\/jaut.1996.0089","article-title":"Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase","volume":"9","author":"Abiru","year":"1996","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.pcd.2014.09.003_bib0090","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.diabres.2004.02.019","article-title":"Clinical and genetic characteristics of GAD-antibody positive patients initially diagnosed as having type 2 diabetes","volume":"66","author":"Hamaguchi","year":"2004","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.pcd.2014.09.003_bib0095","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.metabol.2006.04.006","article-title":"Clinical and biochemical characteristics of nonobese type 2 diabetic patients with glutamic acid decarboxylase antibody in Korea","volume":"55","author":"Kim","year":"2006","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.pcd.2014.09.003_bib0100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.beem.2004.11.010","article-title":"Diabetes-related antibodies in adult diabetic patients","volume":"19","author":"Falorni","year":"2005","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.pcd.2014.09.003_bib0105","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.metabol.2006.04.006","article-title":"Clinical and biochemical characteristics of nonobese type 2 diabetic patients with glutamic acid decarboxylase antibody in Korea","volume":"55","author":"Kim","year":"2006","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.pcd.2014.09.003_bib0110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pcd.2008.08.003","article-title":"Easily obtainable clinical features increase the diagnostic accuracy for latent autoimmune diabetes in adults: an evidence-based report","volume":"2","author":"Lutgens","year":"2008","journal-title":"Prim. Care Diabetes"},{"key":"10.1016\/j.pcd.2014.09.003_bib0115","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/meta.2001.25654","article-title":"Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1\/2) diabetes in patients presenting with type 2 diabetes","volume":"50","author":"Juneja","year":"2001","journal-title":"Metabolism"},{"key":"10.1016\/j.pcd.2014.09.003_bib0120","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s001250051202","article-title":"Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43) UK Prospective Diabetes Study (UKPDS) Group","volume":"42","author":"Horton","year":"1999","journal-title":"Diabetologia"}],"container-title":["Primary Care Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S175199181400103X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S175199181400103X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T23:54:58Z","timestamp":1761695698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S175199181400103X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S175199181400103X"],"URL":"https:\/\/doi.org\/10.1016\/j.pcd.2014.09.003","relation":{},"ISSN":["1751-9918"],"issn-type":[{"type":"print","value":"1751-9918"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Latent autoimmune diabetes amongst adults with type 2 diabetes in a Nigerian tertiary hospital","name":"articletitle","label":"Article Title"},{"value":"Primary Care Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcd.2014.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}